NASDAQ:CRVS | Net Income | Corvus Pharmaceuticals, Inc.

Complete source-backed net income history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Net Income

DateNet Income
2026-06-30-$17.96M
2026-03-31-$13.69M
2025-12-31-$12.32M
2025-09-30-$10.16M
2025-06-30-$8M
2025-03-31$15.19M
2024-12-31-$12.11M
2024-09-30-$40.22M
2024-06-30-$4.26M
2024-03-31-$5.7M
2023-12-31-$6.65M
2023-09-30-$6M
2023-06-30-$6.5M
2023-03-31-$7.87M
2022-12-31-$9.82M
2022-09-30-$14.83M
2022-06-30-$8.36M
2022-03-31-$8.3M
2021-12-31-$9.24M
2021-09-30-$10.67M
2021-06-30-$11.75M
2021-03-31-$11.58M
2020-12-31$27.35M
2020-09-30-$9.8M
2020-06-30-$10.61M
2020-03-31-$12.94M
2019-12-31-$11.05M
2019-09-30-$11M
2019-06-30-$12.98M
2019-03-31-$11.64M
2018-12-31-$10.51M
2018-09-30-$10.5M
2018-06-30-$11.63M
2018-03-31-$14.3M
2017-12-31-$11.93M
2017-09-30-$12.72M
2017-06-30-$14.98M
2017-03-31-$16.04M
2016-12-31-$11.09M
2016-09-30-$10.3M
2016-06-30-$8.65M
2016-03-31-$6.35M
2015-12-31-$6.04M
2015-09-30-$3.15M
2015-06-30-$20.23M
2015-03-31-$1.91M

Annual Net Income

DateNet Income
2025-12-31-$15.28M
2024-12-31-$62.29M
2023-12-31-$27.03M
2022-12-31-$41.31M
2021-12-31-$43.24M
2020-12-31-$6M
2019-12-31-$46.67M
2018-12-31-$46.94M
2017-12-31-$55.66M
2016-12-31-$36.38M
2015-12-31-$31.34M
2014-12-31-$161,000.00